BIO - Bio-Rad Laboratories, Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue2,289,4152,160,1532,068,1722,019,441
Cost of Revenue1,060,964970,750927,644897,771
Gross Profit1,228,4511,189,4031,140,5281,121,670
Operating Expenses
Research Development198,896227,057205,708192,972
Selling General and Administrative840,683819,390785,821761,990
Non Recurring----
Others-3,3003,3003,300
Total Operating Expenses2,100,5432,020,4971,919,1731,852,733
Operating Income or Loss188,872139,656148,999166,708
Income from Continuing Operations
Total Other Income/Expenses Net323,787-41,851-107,439-20,861
Earnings Before Interest and Taxes188,872139,656148,999166,708
Interest Expense-23,962-21,914-21,942-21,692
Income Before Tax512,65997,80541,560145,847
Income Tax Expense147,045-24,44415,56036,608
Minority Interest----
Net Income From Continuing Ops365,614122,24926,000109,239
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income365,614122,24926,000109,239
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares365,614122,24926,000109,239